The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis
iPeer2Peer
1 other identifier
interventional
164
1 country
6
Brief Summary
The iPeer2Peer program matches teens with arthritis to an older mentor who has learned to manage their arthritis well and can support them emotionally and socially. This study will compare two groups of teens: those who are in the iPeer2Peer Program and those in the control group (no mentor).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2017
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 28, 2017
CompletedFirst Submitted
Initial submission to the registry
March 31, 2017
CompletedFirst Posted
Study publicly available on registry
April 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 16, 2023
CompletedNovember 24, 2023
November 1, 2023
6.1 years
March 31, 2017
November 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
TRANSITION-Q (measuring change)
14-item measure of self-management skills that is both reliable (internally consistent, test-retest) and valid (face, construct and content validity)
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
Secondary Outcomes (14)
PedsQL Arthritis Module (measuring change)
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
PROMIS Pain Interference (measuring change)
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
Screen for Child Anxiety Related Disorders (measuring change)
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
Center for Epidemiologic Studies Depression Scale Revised (measuring change)
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
Medical Issues, Exercise, Pain and Social Support Questionnaire (measuring change)
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
- +9 more secondary outcomes
Study Arms (2)
iPeer2Peer Mentorship
EXPERIMENTALIn addition to standard care, youth in the experimental group will receive the iPeer2Peer program, a peer mentorship program that will provide modeling and reinforcement of self-management by pre-screened and trained peer mentors (young adults with JIA aged 18-22 years who have learned to function successfully with their disease). Mentors will encourage participants to develop and engage in self-management skills and provide social support.
Control Group
ACTIVE COMPARATORThe control group will receive standard care but without the iPeer2Peer program.
Interventions
10 sessions of 20-30 minute Skype calls conducted over 5-12 weeks.
The control group will receive standard care but without the iPeer2Peer program.
Eligibility Criteria
You may qualify if:
- males and females 12-18 years old
- rheumatologist-diagnosed JIA according to ILAR criteria
- able to speak and read English
- access to a computer, smartphone or tablet capable of using free Skype software (note: participants who do not have adequate Internet access will be provided with portable Internet sticks)
- willing and able to complete online measures.
You may not qualify if:
- significant cognitive impairments
- major co-morbid illnesses (medical or psychiatric conditions) likely to influence HRQL assessment
- participating in other peer support or self-management interventions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Hospital for Sick Childrenlead
- Provincial Health Services Authority British Columbiacollaborator
- IWK Health Centrecollaborator
- Children's Hospital of Eastern Ontariocollaborator
Study Sites (6)
Alberta Children's Hospital
Calgary, Alberta, T3B 6A8, Canada
BC Children's Hospital
Vancouver, British Columbia, Canada
The IWK Health Centre
Halifax, Nova Scotia, Canada
Children's Hospital - London Health Sciences
London, Ontario, N6A 5W9, Canada
Children's Hospital of Eastern Ontario (CHEO)
Ottawa, Ontario, Canada
The Hospital for Sick Children
Toronto, Ontario, Canada
Related Publications (1)
Nishat F, Kelenc L, Berard R, Duffy C, Feldman B, Forgeron P, Huber AM, Luca N, Schmeling H, Spiegel L, Tucker L, Watanabe-Duffy K, Killackey T, Lalloo C, Wiles B, Nair A, Olaizola S, McDermott B, Tavangar F, Kohut SA, Stinson JN. Assessing the impact of the iPeer2Peer program for adolescents with juvenile idiopathic arthritis: a mixed-methods randomized controlled trial. Pediatr Rheumatol Online J. 2024 Dec 27;22(1):109. doi: 10.1186/s12969-024-01052-5.
PMID: 39731098DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer N Stinson, CPNP, PhD
The Hospital for Sick Children
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Scientist
Study Record Dates
First Submitted
March 31, 2017
First Posted
April 17, 2017
Study Start
March 28, 2017
Primary Completion
April 16, 2023
Study Completion
April 16, 2023
Last Updated
November 24, 2023
Record last verified: 2023-11